Eunice Smith

 Seasonal Malaria Chemoprevention (SMC) is a critical strategy for programs and policymakers in areas where malaria follows a seasonal pattern. As global health advocacy for expanded scale-up and use grows, so too is the attention given to SMCs at the global level. This article reviews the international movement for SMC, highlighting achievements, challenges, and concerted […]

 Historically seen as a niche for specialist use, seasonal chemoprevention has developed into a powerful weapon against malaria, particularly in regions of intense seasonality of disease. Its success has been most well-documented in Africa, but there is a growing momentum to investigate seasonal chemoprevention in other settings where it may have a role. In this

 Malaria chemoprevention the use of medication to prevent malaria is a potentially game-changing strategy in the battle against this killer disease, especially in high-risk populations such as children and pregnant women who shoulder the greatest burden of the disease. However, bringing the benefits of malaria chemoprevention to a multitude of heterogeneous cultural contexts is bound

 Seasonal Malaria Chemoprevention (SMC) is a vital tool for interrupting the transmission of malaria, which is seasonal in most areas. SMC prevents malaria by administering doses of antimalarial drugs as seasonal transmission of malaria begins, during the peak, and at the end of the season. Given that the geography, epidemiology, and health infrastructure differ depending

 More than four decades later, malaria is still a major public health issue in many countries, and a leading cause of sickness and loss of life, especially in the sub-Saharan African region, which bears a disproportionate burden of the disease. The seasonality of malaria transmission in the region has sparked interest in seasonal strategies for

 The southeastern African country of Mozambique is currently one of the most malaria-endemic countries in the world. It is battling hard against malaria through some innovative public health strategies. One of the key strategies is Seasonal Malaria Chemoprevention (SMC) a mass drug administration intervention that delivers three antimalarial drugs to children under five years old

 Despite significant progress, tens of millions of people in sub-Saharan Africa are still at risk of malaria. New and innovative approaches are therefore required and are emerging. Research conducted in Uganda highlights similar findings to research conducted in Mozambique, but importantly also reveals new avenues of innovation in malaria prevention that could lead to further

 Malaria continues to be a global health priority. The burden of the disease in sub-Saharan Africa in particular is tremendous. Nevertheless, countries such as Uganda and Mozambique have shown how malaria can be managed, and the burden of the disease is significantly reduced. If the success in these countries could be scaled up and transmitted

Seasonal malaria chemoprevention (SMC) actively protects children from malaria during peak transmission periods through a targeted, short-term intervention. Malaria is a seasonal disease, with the vast majority of transmission in endemic districts occurring within two to four months. Based on this observation, SMC involves giving children antimalarial drugs every 14 to 28 days depending on

 Malaria is one of the greatest public health challenges for Uganda. It occurs endemic in Uganda, where millions each year are affected. Despite remarkable progress in the fight against malaria, malaria control remains challenging and complex. This article analyses the malaria situation in Uganda, with a focus on chemoprevention as part of the continuum of